Jul. 5 at 3:02 AM
$MGTX xlrp is probably a bigger market than luxturna’s target.
RPE65:
• Prevalence: ~1 in 80,000 people
• Accounts for 5-6% of all LCA cases
• Much rarer condition overall
XLRP:
• Overall RP prevalence: ~1 in 3,500-4,000 people
• XLRP represents 5-20% of all RP cases (varies by region)
• Estimated prevalence: ~1 in 17,500-80,000 people (calculated from RP prevalence × XLRP proportion)
